Wasatch Advisors Lp
Source: SEC Form 13F · as of Mar 2026Wasatch Advisors Lp holds 20 biotech & pharma companies tracked by BioSniper, totaling $675.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$675.1M
| Company | Shares | Value |
|---|---|---|
| MEDPMedpace Holdings Inc. | 773,931 | $371.6M |
| RGENREPLIGEN CORP | 1,243,531 | $146.5M |
| ESPREsperion Therapeutics, Inc. | 15,768,897 | $43.2M |
| PHATPhathom Pharmaceuticals, Inc. | 1,340,916 | $14.9M |
| CSTLCastle Biosciences Inc. | 455,036 | $11.2M |
| VKTXViking Therapeutics, Inc. | 313,158 | $10.2M |
| DERMJourney Medical Corp | 2,133,370 | $10.0M |
| DYNDyne Therapeutics, Inc. | 443,668 | $8.0M |
| CCCCC4 Therapeutics, Inc. | 2,961,761 | $7.8M |
| JNJJOHNSON & JOHNSON | 29,864 | $7.3M |
| INSPInspire Medical Systems Inc. | 138,603 | $7.1M |
| TLSITriSalus Life Sciences Inc. | 1,437,960 | $5.8M |
| PRCTPROCEPT BioRobotics Corporation | 222,644 | $5.6M |
| IMTXImmatics N.V. | 464,823 | $4.6M |
| MGNXMACROGENICS INC | 1,559,701 | $4.5M |
| AQSTAquestive Therapeutics, Inc. | 878,316 | $3.6M |
| DGXQuest Diagnostics Incorporated | 17,702 | $3.5M |
| NTLAIntellia Therapeutics, Inc. | 261,864 | $3.4M |
| NKTXNkarta, Inc. | 1,577,847 | $3.3M |
| ARVNARVINAS, INC. | 281,857 | $3.0M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.